Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Stephen Proctor

Newcastle AuthorsTitleYearFull text
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Anne Lennard
Impact of p53 positive p21 negative phenotype on outcome in CHOP-R treated DLBCL patients2014
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Paul Milne
et al.		Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients2013
Professor Stephen Proctor
Dr Jennifer Wilkinson
Gillian Watson
Dr Helen Lucraft
Dr Tryfonia Mainou-Fowler
et al.		Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study2012
Professor Stephen Proctor
Dr Jennifer Wilkinson
Dr Helen Lucraft
Dr Richard McNally
Dr Tryfonia Mainou-Fowler
et al.		Comparative clinical responses of three chemotherapy schedules (VEPEMB, ABVD, CLVPP) in 175 Hodgkin Lymphoma patients over 60ys evaluated as part of the Shield (Hodgkin elderly) Study2011
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Professor Stephen Proctor
Dr Brian Angus
Dr Stephen Crosier
Dr John Anderson
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al.		A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines2010
Professor Anthony Moorman
Dr Lucy Chilton
Dr Jennifer Wilkinson
Hannah Ensor
Dr Nicholas Bown
et al.		A population-based cytogenetic study of adults with acute lymphoblastic leukemia2010
Professor Anthony Moorman
Dr Lucy Chilton
Dr Jennifer Wilkinson
Hannah Ensor
Natalie Bown
et al.		Age- and sex-adjusted incidence rates of adults with acute lymphoblastic leukemia (ALL) in the northern part of England Response2010
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation2010
Dr Rachel Crossland
Professor Stephen Proctor
Professor James Allan
Mature MicroRNAs Mir 18, 19a, 19b, 17 5p and 92 of the Mir 17 92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia2010
Dr Rachel Crossland
Professor Stephen Proctor
Professor James Allan
Dr Tryfonia Mainou-Fowler
Mature MicroRNAs Mir-18,-19a,-19b,-17-5p and-92 of the Mir-17-92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia2010
Professor Stephen Proctor
Dr Anne Lennard
Professor Graham Jackson
Dr Jennifer Wilkinson
Dr Michal Sieniawski
et al.		The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control2010
Dr Michal Sieniawski
Dr Malcolm Farrow
Elaine Zhao
Dr Jennifer Wilkinson
Dr Tryfonia Mainou-Fowler
et al.		A Novel Bayesian Prognostic Index for Diffuse Large B-Cell Lymphoma: A New Powerful Tool for Prediction Of Outcome2009
Dr Michal Sieniawski
Professor Stephen Proctor
Dr Anne Lennard
Aggressive Primary Chemotherapy Plus Autologous Stem Cell Transplantation Improves Outcome for Peripheral T Cell Lymphomas Compared with CHOP-Like Regimens2009
12345678910111213141516